From Alex Coliville at age1 venture capital.
Source: https://x.com/AlexJColville/status/1759987917189976557?s=20
6 Likes
And more good reasons on why scientists should be getting into longevity startups… all the people like Belmonte, Yamanaka, Horvath, Levine, etc. who are running their own labs/groups seem likely to have gotten in the range of 1% of the stock, and at the Series B fundraise premoney valuation may already be worth $37 Million (after only a year of work)…
Source: https://x.com/AlexJColville/status/1763262822136590588?s=20
More on Altos: Bezos' Altos Labs Officially Launches with $3 Billion in Funding
2 Likes